West Pharmaceutical Services (WST) Long-Term Investments (2009 - 2026)

West Pharmaceutical Services' Long-Term Investments history runs 18 years deep, the most recent figure standing at $209.2 million for Q1 2026.

• In Q1 2026, Long-Term Investments fell 1.27% year-over-year to $209.2 million; the TTM figure through Mar 2026 stood at $209.2 million (down 1.27% YoY), while the FY2025 annual figure was $212.3 million, up 5.05% from the prior year.
• Long-Term Investments came in at $209.2 million for Q1 2026 at West Pharmaceutical Services, down from $212.3 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $224.7 million in Q2 2025 to a low of $188.6 million in Q3 2022.
• A 5-year average of $206.5 million and a median of $208.1 million in 2022 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments decreased 12.56% in 2022 and climbed 13.37% in 2025, its largest moves.
• West Pharmaceutical Services' Long-Term Investments stood at $204.9 million in 2022, then increased by 2.49% to $210.0 million in 2023, then dropped by 3.76% to $202.1 million in 2024, then grew by 5.05% to $212.3 million in 2025, then dropped by 1.46% to $209.2 million in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $209.2 million, $212.3 million, and $220.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison